title: Complement activation decreases the ability of HIV transmembrane envelope protein to bind to specific antibody.
authors.forename: F
authors.initials: F
authors.lastname: el Jarrah
authors.forename: T
authors.initials: T
authors.lastname: Hidvégi
authors.forename: E
authors.initials: E
authors.lastname: Ujhelyi
authors.forename: G
authors.initials: G
authors.lastname: Gyapay
authors.forename: V
authors.initials: V
authors.lastname: Salavecz
authors.forename: J J
authors.initials: JJ
authors.lastname: Origer
authors.forename: S
authors.initials: S
authors.lastname: Hollán
authors.forename: G
authors.initials: G
authors.lastname: Füst
mesh_terms: D000818:Animals; D003167:Complement Activation; D006168:Guinea Pigs; D015483:HIV Antibodies / Q000276:immunology*; D015700:HIV Envelope Protein gp41 / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D011994:Recombinant Proteins / Q000276:immunology
chemical_list: D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41; D011994:Recombinant Proteins